Neuronetics (STIM) Equity Ratio (2017 - 2025)
Neuronetics (STIM) has disclosed Equity Ratio for 9 consecutive years, with 0.19 as the latest value for Q3 2025.
- On a quarterly basis, Equity Ratio rose 48.58% to 0.19 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.19, a 48.58% increase, with the full-year FY2024 number at 0.2, down 33.38% from a year prior.
- Equity Ratio was 0.19 for Q3 2025 at Neuronetics, down from 0.23 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.67 in Q1 2021 to a low of 0.13 in Q3 2024.
- A 5-year average of 0.41 and a median of 0.45 in 2023 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: soared 86.09% in 2021, then crashed 68.98% in 2024.
- Neuronetics' Equity Ratio stood at 0.6 in 2021, then fell by 19.06% to 0.49 in 2022, then tumbled by 39.54% to 0.3 in 2023, then plummeted by 33.38% to 0.2 in 2024, then dropped by 4.36% to 0.19 in 2025.
- Per Business Quant, the three most recent readings for STIM's Equity Ratio are 0.19 (Q3 2025), 0.23 (Q2 2025), and 0.28 (Q1 2025).